Advoca CAIHL draft report

HugoScore CAIHL Draft Report: Advoca

Status: Draft for human review Generated: 2026-06-08 Last reviewed: 2026-06-08 Review method: Deep public-source review of official product pages, privacy policy, consumer health data policy, terms, partner references, and available independent coverage; no vendor interview or hands-on testing. Service: Advoca Vendor: Advoca Health Ltd Category: Patient visit companion / complex-care health copilot

Executive Summary

Advoca is a patient-facing app for cancer patients, rare disease patients, carers, and people managing complex care. It supports appointment planning, visit recording, plain-language summaries, trusted-source follow-up questions, and optional sharing.

From a CAIHL perspective, Advoca is potentially agency-expanding because it is patient/carer-chosen and built around memory, preparation, understanding, and follow-through. It also has detailed public privacy documentation. The profile remains draft because independent accuracy, equity, accessibility, and patient-outcome evidence are still needed.

Agency posture: Potentially agency-expanding Confidence: Medium draft

Evidence

• Advoca homepage: https://advocahealth.com/
• Advoca Privacy Policy: https://advocahealth.com/privacy.html
• Advoca Consumer Health Data Privacy Policy: https://advocahealth.com/consumer-health-data-privacy-policy.html
• Advoca Terms and Conditions: https://advocahealth.com/terms.html
• STAT market context: https://www.statnews.com/2026/06/04/after-doctors-patient-ai-scribes-track-visits/

Mixed HugoScore Profile

• Who does this AI serve? Patient-directed. It is designed for patients and carers facing complex care.
• Can patients tell AI is involved? Yes. Recording, summarization, and chatbot features are explicit.
• Can patients meaningfully choose? Yes. Use is voluntary and user initiated, though recording consent remains jurisdiction-specific.
• Can patients correct or challenge what the AI produces? Partial. Public policy describes access, rectification, deletion, portability, and reporting inaccuracies, but the editing workflow needs review.
• Does it help patients understand or act? Yes. Appointment planning, summaries, trusted sources, follow-up questions, and sharing directly support action.

Patient Agency Interpretation

Advoca is one of the stronger Batch 1 patient-agency candidates because it is built for patients and carers rather than for institutional documentation. Its risk is overconfidence in summaries and chatbot answers, especially if uncertainty, source limits, and correction pathways are not prominent in the app experience.

Publication Recommendation

Ready for human review as a draft profile. Final publication should wait for app-level verification of recording consent, editing/correction, export, sharing revocation, source curation, and independent accuracy evidence.